Dumville Jo C, McFarlane Emma, Edwards Peggy, Lipp Allyson, Holmes Alexandra, Liu Zhenmi
School of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK, M13 9PL.
Cochrane Database Syst Rev. 2015 Apr 21;2015(4):CD003949. doi: 10.1002/14651858.CD003949.pub4.
BACKGROUND: Surgical site infection rates in the month following clean surgery vary from 0.6% (knee prosthesis) to 5% (limb amputation). Due to the large number of clean surgical procedures conducted annually the costs of these surgical site infections (SSIs) can be considerable in financial and social terms. Preoperative skin antisepsis using antiseptics is performed to reduce the risk of SSIs by removing soil and transient organisms from the skin where a surgical incision will be made. Antiseptics are thought to be toxic to bacteria and therefore aid their mechanical removal. The effectiveness of preoperative skin preparation is thought to be dependent on both the antiseptic used and the method of application, however, it is unclear whether preoperative skin antisepsis actually reduces postoperative wound infection, and, if so, which antiseptic is most effective. OBJECTIVES: To determine whether preoperative skin antisepsis immediately prior to surgical incision for clean surgery prevents SSI and to determine the comparative effectiveness of alternative antiseptics. SEARCH METHODS: For this third update we searched just the Cochrane Wounds Group Specialised Register (searched 27 January 2015); The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2014, Issue 12). SELECTION CRITERIA: Randomised controlled trials evaluating the use of preoperative skin antiseptics applied immediately prior to incision in clean surgery. There was no restriction on the inclusion of reports based on language of publication, date or publication status. DATA COLLECTION AND ANALYSIS: Data extraction and assessment of risk of bias were undertaken independently by two review authors. MAIN RESULTS: There were no new studies added to the review in the third updateThirteen studies were included in this review (2,623 participants). These evaluated several different types of skin antiseptics - leading to 11 different comparisons being made. Although the antiseptics evaluated differed between studies, all trials involved some form of iodine. Iodine in alcohol was compared to alcohol alone in one trial; one trial compared povidone iodine paint (solution type not reported) with soap and alcohol. Six studies compared different types of iodine-containing products with each other and five compared iodine-containing products with chlorhexidine-containing products.There was evidence from one study suggesting that preoperative skin preparation with 0.5% chlorhexidine in methylated spirits led to a reduced risk of SSI compared with an alcohol based povidone iodine solution: RR 0.47 (95% CI 0.27 to 0.82). However, it is important to note that the trial does not report important details regarding the interventions (such as the concentration of povidone iodine paint used) and trial conduct, such that risk of bias was unclear.There were no other statistically significant differences in SSI rates in the other comparisons of skin antisepsis. Overall the risk of bias in included studies was unclear.A mixed treatment comparison meta-analysis was conducted and this suggested that alcohol-containing products had the highest probability of being effective - however, again the quality of this evidence was low. AUTHORS' CONCLUSIONS: A comprehensive review of current evidence found some evidence that preoperative skin preparation with 0.5% chlorhexidine in methylated spirits was associated with lower rates of SSIs following clean surgery than alcohol-based povidone iodine paint. However this single study was poorly reported. Practitioners may therefore elect to consider other characteristics such as costs and potential side effects when choosing between alternatives.The design of future trials should be driven by the questions of high priority to decision makers. It may be that investment in at least one large trial (in terms of participants) is warranted in order to add definitive and hopefully conclusive data to the current evidence base. Ideally any future trial would evaluate the iodine-containing and chlorhexidine-containing solutions relevant to current practice as well as the type of solution used (alcohol vs. aqueous).
背景:清洁手术后一个月内手术部位感染率在0.6%(膝关节假体)至5%(肢体截肢)之间。由于每年进行大量的清洁手术,这些手术部位感染(SSI)的成本在经济和社会方面都可能相当可观。术前使用消毒剂进行皮肤消毒,通过清除手术切口部位皮肤的污垢和暂住菌,以降低SSI的风险。消毒剂被认为对细菌有毒性,因此有助于机械性清除细菌。术前皮肤准备的效果被认为取决于所使用的消毒剂和应用方法,然而,目前尚不清楚术前皮肤消毒是否真的能降低术后伤口感染率,如果能降低,哪种消毒剂最有效。 目的:确定清洁手术术前手术切口即刻进行皮肤消毒是否能预防SSI,并确定不同消毒剂的相对有效性。 检索方法:本次第三次更新仅检索了Cochrane伤口组专业注册库(2015年1月27日检索);Cochrane对照试验中央注册库(CENTRAL)(《Cochrane图书馆》2014年第12期)。 选择标准:评估清洁手术术前切口即刻使用皮肤消毒剂的随机对照试验。纳入报告不受发表语言、日期或发表状态的限制。 数据收集与分析:两名综述作者独立进行数据提取和偏倚风险评估。 主要结果:第三次更新中未纳入新的研究。本综述纳入了13项研究(2623名参与者)。这些研究评估了几种不同类型的皮肤消毒剂,共进行了11种不同的比较。尽管不同研究中评估的消毒剂不同,但所有试验都涉及某种形式的碘。一项试验将酒精中的碘与单纯酒精进行比较;一项试验将聚维酮碘涂剂(溶液类型未报告)与肥皂和酒精进行比较。六项研究相互比较了不同类型的含碘产品,五项研究将含碘产品与含氯己定产品进行比较。有一项研究的证据表明,与酒精基聚维酮碘溶液相比,术前用含0.5%氯己定的变性酒精进行皮肤准备可降低SSI风险:相对危险度0.47(95%可信区间0.27至0.82)。然而,需要注意的是,该试验未报告有关干预措施(如所用聚维酮碘涂剂的浓度)和试验实施的重要细节,因此偏倚风险尚不清楚。在其他皮肤消毒比较中,SSI发生率没有其他统计学上的显著差异。总体而言,纳入研究的偏倚风险尚不清楚。进行了混合治疗比较的Meta分析,结果表明含酒精产品最有可能有效,但同样,该证据的质量较低。 作者结论:对现有证据的全面综述发现,有证据表明,与酒精基聚维酮碘涂剂相比,术前用含0.5%氯己定的变性酒精进行皮肤准备与清洁手术后较低的SSI发生率相关。然而,这项单一研究报告不充分。因此,从业者在选择替代方案时,可能会选择考虑其他因素,如成本和潜在副作用。未来试验的设计应以决策者高度关注为导向。可能有必要投资至少一项大型试验(就参与者数量而言),以便为当前证据库增加确切且有望具有决定性的数据。理想情况下,未来任何试验都应评估与当前实践相关的含碘和含氯己定溶液以及所用溶液类型(酒精与水性)。
Cochrane Database Syst Rev. 2015-4-21
Cochrane Database Syst Rev. 2013-3-28
Cochrane Database Syst Rev. 2016-7-13
Cochrane Database Syst Rev. 2017-10-30
Cochrane Database Syst Rev. 2017-7-12
Cochrane Database Syst Rev. 2013-12-23
Cochrane Database Syst Rev. 2016-1-22
Cochrane Database Syst Rev. 2025-6-9
Cochrane Database Syst Rev. 2016-3-29
Cochrane Database Syst Rev. 2017-5-18
Front Med (Lausanne). 2025-8-8
Plast Surg (Oakv). 2024-11
Rev Cardiovasc Med. 2024-1-10
J Antimicrob Chemother. 2014-8
Cochrane Database Syst Rev. 2012-9-12
J Eur Acad Dermatol Venereol. 2013-7
Infect Control Hosp Epidemiol. 2012-4-16
Diabetologia. 2012-4-29
Rev Obstet Gynecol. 2009